Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer

This study has been withdrawn prior to enrollment.
(implementation issues)
Sponsor:
Collaborators:
National Institutes of Health (NIH)
Biolitec Pharma Ltd.
Information provided by (Responsible Party):
Roswell Park Cancer Institute
ClinicalTrials.gov Identifier:
NCT01718223
First received: October 29, 2012
Last updated: September 2, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: August 2014
  Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)